Clearance of NRL972 in Patients With Cirrhosis and in Healthy Volunteers

NCT00856713 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Cirrhosis

Interventions

DRUG: NRL972
DRUG: NRL972
DRUG: NRL972
DRUG: NRL972
DRUG: NRL972
DRUG: NRL972

Sponsor

Norgine